Givaudan (OTCMKTS:GVDNY - Get Free Report) was downgraded by equities researchers at Barclays from a "strong-buy" rating to a "hold" rating in a research report issued to clients and investors on Friday,Zacks.com reports.
GVDNY has been the topic of a number of other reports. Citigroup restated a "neutral" rating on shares of Givaudan in a research note on Tuesday, February 3rd. The Goldman Sachs Group downgraded shares of Givaudan from a "strong-buy" rating to a "sell" rating in a research note on Tuesday, February 10th. Finally, Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Givaudan in a report on Friday, January 30th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold".
Check Out Our Latest Research Report on Givaudan
Givaudan Stock Down 0.2%
Shares of Givaudan stock opened at $66.08 on Friday. The firm's fifty day simple moving average is $76.00 and its 200-day simple moving average is $80.24. Givaudan has a 12 month low of $65.97 and a 12 month high of $103.39. The company has a quick ratio of 1.13, a current ratio of 1.74 and a debt-to-equity ratio of 0.92.
Givaudan Company Profile
(
Get Free Report)
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company's core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.